Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

511 results about "Potentiator" patented technology

In clinical terms, a potentiator is a reagent that enhances sensitization of an antigen. Potentiators are used in the clinical laboratory for performing blood banking procedures that require enhancement of Agglutination (biology) to detect the presence of antibodies or antigens in a patient's blood sample. Examples of potentiators include albumin, LISS (low ionic-strength saline) and PEG (polyethylene glycol). Potentiators are also known as enhancement reagents.

Kit and method for detecting common fusion genes of lymphoid leukemia based on multiple digital PCR (Polymerase Chain Reaction) method

The invention provides a kit and a method for detecting common fusion genes of lymphoid leukemia based on a multiple digital PCR (Polymerase Chain Reaction) method. By constructing a synergistic effect mechanism of the primer and the fluorescent probe and optimizing matching of the primer, the probe and a fluorescent marker, non-specific binding among amplification products is effectively avoided. A composite reaction aid with a specific formula, namely a PCR enhancer, is innovatively introduced, so that the amplification efficiency and specificity of a multiple detection system are remarkably improved. According to the kit provided by the invention, the integrated detection capability on seven fluorescent channels, namely Atto 425, VIC, FAM, ROX, CY5, CY5.5 and CY7, is realized in a single-hole design. By innovatively constructing an ROX + CY5 and Atto425 + VIC dual-channel joint detection system, when the ROX and CY5 channels or Atto425 and VIC channels in the same detection hole simultaneously present positive signals, two additional detection targets can be specifically interpreted. The innovative detection strategy based on channel combination enables the kit to realize precise detection of 18 fusion genes only through two detection holes in a breakthrough manner.
Owner:INVP (ZHEJIANG) BIOTECHNOLOGY CO LTD

Traditional Chinese medicine transdermal drug delivery preparation based on nano-coating technology and preparation method of traditional Chinese medicine transdermal drug delivery preparation

The invention relates to the field of nano-drug delivery preparations, in particular to a traditional Chinese medicine transdermal drug delivery preparation based on a nano-coating technology and a preparation method thereof, the traditional Chinese medicine transdermal drug delivery preparation comprises a liposome-metal organic framework composite carrier, and the composite carrier comprises traditional Chinese medicine active ingredients; a meridian point targeted transdermal enhancer; an iontophoresis device for dynamically sensing skin impedance; the invention relates to an intelligent administration time sequence control system based on a traditional Chinese medicine midnight-noon ebb-flow theory. The liposome-metal organic framework composite carrier is adopted, the similar structure of liposome and skin and the high specific surface area of MOF are fully utilized, efficient encapsulation and transdermal absorption of active ingredients of traditional Chinese medicine are achieved, and compared with a traditional transdermal patch, the drug transdermal absorption rate is increased by 3-5 times.
Owner:SHENZHEN TRADITIONAL CHINESE MEDICINE HOSPITAL

Nano-drug for targeted diagnosis and treatment of atherosclerotic plaque

The invention provides a nano-drug for targeted diagnosis and treatment of atherosclerotic plaque, the nano-particles are constructed by EGCG, formaldehyde and L-arginine, the antioxidant characteristic of EGCG is retained, and the nano-drug constructed by modifying Mn < 2 + > and DKK1 antibodies on the basis has a good relaxation value and can be used for an atherosclerotic plaque specific MRI imaging enhancer; the Cy5-labeled nano-drug can be used for an atherosclerotic plaque specific in-vivo imaging developer. The nano-drug provided by the invention has good biological safety, can delay plaque development and improve plaque stability, and is a nano-drug for precisely targeting atherosclerotic plaque and treating the atherosclerotic plaque.
Owner:SHANDONG UNIV QILU HOSPITAL

Detection method for detecting low-abundance myocardial MicroRNA-155 based on Janus platinum nano-enzyme enhanced tyramine signal amplification probe

The invention discloses a method for detecting low-abundance myocardial MicroRNA-155 based on a tyramine signal amplification probe enhanced by Janus platinum nano enzyme. Janus platinum nano particles are formed by assembling platinum nano particles and silicon dioxide under a mild condition and have relatively high catalytic activity. The invention further discloses a method for detecting the low-abundance myocardial MicroRNA-155 based on the tyramine signal amplification probe enhanced by the Janus platinum nano enzyme. Quantitative detection and analysis are carried out on the myocardial microRNA-155 by combining the specificity of nucleic acid hybridization reaction and taking tyramine modified platinum nanoparticles as a signal amplification enhancer. The method comprises the following steps: carrying out surface amination on Janus platinum nano-enzyme, preparing a nucleic acid probe labeled by the Janus platinum nano-enzyme, preparing a tyramine modified platinum nano-particle signal amplification enhancer, and establishing the tyramine signal amplification probe enhanced by the Janus platinum nano-enzyme to accurately measure the content of the low-abundance myocardial MicroRNA-155. The detection method disclosed by the invention is simple to operate, high in sensitivity and strong in specificity, and can realize high-throughput nondestructive detection.
Owner:THE FIRST AFFILIATED HOSPITAL OF WANNAN MEDICAL COLLEGE (YIJISHAN HOSPITAL OF WANNAN MEDICAL COLLEGE)

Application of bleomycin as immunopotentiator

The invention belongs to the technical field of biological medicines, and particularly relates to application of bleomycin or bleomycin analogues in preparation of an immunopotentiator. The invention also provides a pharmaceutical composition and application of the pharmaceutical composition in preparation of drugs for treating and / or preventing cancers. The pharmaceutical composition comprises bleomycin, bleomycin analogues or a combination thereof and an anti-tumor immunotherapeutic agent.
Owner:CHONGQING MEDICAL UNIVERSITY

Kit for rapidly and quantitatively detecting human parvovirus B19, primer probe combination and application thereof

The invention discloses a kit for rapidly and quantitatively detecting human parvovirus B19, a primer probe combination and application thereof. The kit comprises a B19 primer probe mixed solution, a B19 enzyme mixed solution and a B19 PCR reaction solution, wherein the B19 PCR reaction liquid comprises a PCR reinforcing agent, and the PCR reinforcing agent comprises a nano material type PCR reinforcing agent, a small molecule chemical type PCR reinforcing agent and a protein type PCR reinforcing agent. The primer pair, the probe and the kit provided by the invention are simple and convenient to use and operate, wide in applicable population and high in detection sensitivity, can detect viral nucleic acid as low as 100IU / mL, and are beneficial to early diagnosis.
Owner:ANHUI TONGKE BIOTECHNOLOGY CO LTD

Dendrobium huoshanense polysaccharide nanoemulsion immunologic adjuvant and preparation method thereof

The invention discloses a dendrobium huoshanense polysaccharide nanoemulsion immunologic adjuvant and a preparation method thereof. The dendrobium huoshanense polysaccharide nanoemulsion immunologic adjuvant is prepared from the following raw materials in percentage by mass: 0.1%-2.0% of dendrobium huoshanense polysaccharide, 20%-30% of a surfactant, 5%-10% of a cosurfactant, 5%-10% of an oil phase and the balance of deionized water. The preparation method of the nano-emulsion is simple and easy to implement, equipment is easy to control, the cost is low, and the obtained nano-emulsion is small in droplet particle size, high in stability and capable of improving the spleen lymphocyte proliferation activity of immunocompromised mice. The nanoemulsion can significantly improve the immunomodulatory activity of dendrobium huoshanense polysaccharide, and has the potential of developing immunopotentiators, thereby promoting the development and utilization of traditional Chinese medicine resources and active components thereof.
Owner:WEST ANHUI UNIV

Immunogenic composition containing adjuvant as well as preparation method and application of immunogenic composition

The invention discloses an immunogenic composition containing an adjuvant as well as a preparation method and application of the immunogenic composition. The immunogenic composition comprises self-assembled gE virus-like nanoparticles, an immunopotentiator, namely, saponin QS-21, and a neutral liposome, the self-assembled gE virus-like nanoparticles are formed by polymerizing and assembling monomers; the monomers include VZV gE, a linker peptide (SGS), and a VZV gI polypeptide containing a Th epitope. The immunogenic composition can be applied to varicella-zoster virus vaccines, and solves the technical problems of weak gE immunogenicity and serious vaccine side reaction in vaccines prepared in the prior art. The immunogenicity of the vaccine is equivalent to that of the Xinanlii, and the use of an immunopotentiator in the vaccine can be reduced, so that the clinical side reaction of the vaccine is lower; in addition, the vaccine can induce a gI specific antibody and gI specific CMI reaction, and the effectiveness of the vaccine can be further improved. In short, the immunogenic composition has good clinical application potential.
Owner:YUNNAN CHANGHE BIOTECHNOLOGY CO LTD

Preparation method and application of diagnosis and treatment agent for tumor radiotherapy sensitization

The invention provides a preparation method and application of a diagnosis and treatment agent for tumor radiotherapy sensitization, and belongs to the field of pharmacy. According to the method, a one-pot method is innovatively adopted to load D-mannose and manganese-coated gold nanoparticles (Au (at) MnO2NPs) into ZIF-8 nanoparticles, and the nano diagnosis and treatment agent (Dman / Au (at) MnO2ZIF-8) for tumor radiotherapy sensitization is prepared. The prepared composite nano diagnosis and treatment agent is enriched in tumor tissues by enhancing permeation and retention effects, releases D-mannose, gold nanoparticles and Mn < 2 + > capable of generating T1 magnetic resonance (MR) imaging signals, and realizes tumor radiotherapy sensitization under the guidance of MR imaging. Besides, D-mannose can further increase the sensitivity of tumor cells to ionizing radiation by inducing protein degradation of a tumor cell programmed death receptor-ligand 1, so that a synergistic treatment effect is achieved, and a new thought is expected to be provided for integration of radiotherapy sensitization and diagnosis and treatment of tumors.
Owner:XUZHOU MEDICAL UNIVERSITY

Water-in-oil-in-water adjuvant, veterinary vaccine and preparation method thereof

The invention belongs to the technical field of vaccine adjuvants, and particularly relates to a water-in-oil-in-water adjuvant, a veterinary vaccine and a preparation method thereof.The water-in-oil-in-water adjuvant is prepared from, by weight, 0.5%-7.5% of a hydrophilic composite surfactant, 0.6%-9.8% of an oleophylic composite surfactant, 70%-85% of mineral oil and the balance water; and the mineral oil also comprises the following components in concentration: a reinforcing agent of 0.45-0.9 g / ml and a stabilizing agent of 2-6.9 g / L, wherein the water-in-oil-in-water adjuvant forms a gelatinous structure under the regulation of the stabilizer and is a non-Newtonian fluid of which the viscosity is not higher than 25cp; the adjuvant shows the non-flowing fluid characteristic through the stabilizer, the rheological property of the produced vaccine is enhanced, the stability of the vaccine is improved, on the premise that the hydrophilic surfactant and the oleophylic surfactant are balanced, the natural polymer enhancer is added, and on the premise that the adjuvant viscosity is reduced and granuloma side reaction is not prone to being generated, the stability of the vaccine is improved. Short-term immunity and long-term immunity can be induced at the same time, and the application of the water-in-oil-in-water adjuvant in the field of veterinary vaccines is expanded.
Owner:JINYUBAOLING BIO PHARMA CO LTD

Systems and methods for infection control in medical implants and biological conduits using electroporation

Systems and methods for infection prevention and treatment in biological conduits using electroporation or pulsed field ablation (PFA). The system includes an elongate member, such as a dialysis catheter, vascular access device, or peritoneal dialysis conduit, with at least one electrode positioned along, within, or around the member. A control unit applies pulsed electric fields to inhibit microbial colonization, disrupt bacterial biofilms, and alter permeability of bacterial or endothelial cells to enhance sterility or fluid exchange. The system may use real-time impedance monitoring, microbial detection, or fluid composition analysis to adjust electroporation parameters. Electroporation may synchronize with dialysis cycles or antimicrobial lock solutions. The method includes automated, clinician-controlled, or sensor-triggered treatments to reduce infections and improve device longevity. The system provides an alternative or augment to antibiotics, reducing the risk of drug-resistant infections while improving the longevity and safety of medical implants.
Owner:ABLATION INNOVATIONS LLC

Optimized expression cassettes for gene therapy

In some aspects, cardiac-specific expression cassettes are provided herein. In some aspects, provided herein is an expression cassette comprising a polynucleotide sequence encoding a gene product for therapy of a heart disease, wherein the polynucleotide sequence is operably linked to promoter (e.g., a cardiac-specific promoter), and optionally an enhancer (e.g., a cardiac-specific enhancer). In some aspects, the disclosure provides recombinant adeno-associated virus (rAAV) virions, comprising a capsid protein and a viral genome comprising an expression cassette comprising a polynucleotide sequence encoding a therapeutic gene product, e.g., dwarf open reading frame (DWORF) polypeptide, operably linked to a promoter, the expression cassette flanked by inverted terminal repeats. The disclosure further provides pharmaceutical compositions and methods of treating or preventing heart disease.
Owner:TENAYA THERAPEUTICS INC

Application of sodium bicarbonate in preparation of MSLN-CAR-T solid tumor treatment enhancer

The invention discloses application of sodium bicarbonate in preparation of a reinforcing agent for treating solid tumors by MSLN-CAR-T. After the solid tumors are treated by sodium bicarbonate, MSLN-CAR-T is used for treatment, so that the treatment effect of MSLN-CAR-T in the solid tumors is improved, a new thought is provided for treating the solid tumors by CAR-T, and a foundation is laid for clinical solid tumor treatment.
Owner:THE FIRST AFFILIATED HOSPITAL OF ARMY MEDICAL UNIV

Anticoagulant compounds comprising chelating agents and cationic Anti-coagulation enhancers and methods and devices for their use

Devices, systems, and methods are provided including a structure having one or more surfaces configured for internal use within a patient's body and one or more therapeutic compositions comprising one or more active substances including at least one of a chelating agent, a direct factor Xa inhibitor, a direct factor IIa inhibitor, and a factor XI / XIa inhibitor disposed in or on the structure. The structure is configured to be positioned adjacent a target site in the patient's body. The therapeutic composition is formulated to release the one or more active substances to the target site to provide one or more of inhibit clot formation, promote clot dissolution, inhibit or dissolute inflammation, inhibit vessel injury, increase time before clotting, and / or inhibit cell proliferation. Delayed or other controlled release of the therapeutic composition from the structure may be provided.
Owner:ELIXIR MEDICAL CORP

Engineered extracellular vesicles with improved cargo delivery

An engineered extracellular vesicle (EV) for delivering a bioactive cargo, the engineered EV comprising an endosomal escape enhancer and a cargo. Plasmids, polynucleotide sequences, cells, methods of making and analysis, pharmaceutical compositions and uses thereof.
Owner:EVOX THERAPEUTICS LTD

System and method for providing enhancing or contrast agent advisability indicator

A system and method for providing an enhancing or contrast agent advisability indicator. Subject data for a subject is processed using an AI-based model to obtain an indication of whether a medical imaging procedure for the subject requires an enhancing or contrast agent. The enhancing or contrast agent advisability indicator is generated with respect to one or more target pathologies assessed in the medical imaging procedure.
Owner:KONINKLIJKE PHILIPS NV

Transfection enhancement method for improving transient transfection efficiency of plasmids

The invention belongs to the technical field of gene transfection, and discloses a transfection enhancement method for improving transient transfection efficiency of plasmids, which comprises the following steps: step 1, plasmid extraction: extracting plasmids by using an endotoxin-removing plasmid extraction kit; 2, preparing cells before transfection; and the cells are recovered and cultured, so that the density of the cells reaches 70-90% during transfection. Step 3, transfection: 1) adding a proper amount of the serum-free culture medium into one centrifugal tube under a sterile condition, then adding a transfection reagent, and fully and uniformly mixing; 2) adding the serum-free culture medium and a reinforcing agent into the other centrifugal tube, fully and uniformly mixing, and then adding plasmids. According to the scheme, the transient transfection efficiency and effect of plasmids are comprehensively improved from plasmid extraction, cell preparation, transfection compound formation to subsequent treatment through a series of optimization steps. Meanwhile, cytotoxicity and stress reaction are reduced, and the cell survival rate and the target protein expression quantity are improved, so that the transfection method becomes an efficient and reliable transfection method.
Owner:IPHASE THERAPEUTICS LTD

Application of pantoprazole in preparation of enhancer for MSLN-CAR-T cell treatment of brain metastatic tumor

The invention discloses an application of pantoprazole in preparation of a reinforcing agent for treating brain metastases by MSLN-CAR-T cells, and the pantoprazole is used for treatment before treatment by the MSLN-CAR-T cells, so that MSLN protein expression, especially expression on cell membranes, is improved, heterogeneity of MSLN target antigen expression is reduced, and homing ability and killing ability of the MSLN-CAR-T cells are improved. A new thought is provided for treating solid tumors through CAR-T cells, and an earlier-stage foundation is laid for related clinical experiments.
Owner:THE FIRST AFFILIATED HOSPITAL OF ARMY MEDICAL UNIV

Multi-mode brain-targeted intelligent nano-drug system aiming at brain glioma and preparation method of multi-mode brain-targeted intelligent nano-drug system

The invention discloses a multi-mode brain-targeted intelligent nano-drug system aiming at brain glioma and a preparation method of the multi-mode brain-targeted intelligent nano-drug system. According to the system, a dual enhancer MnO2 nanoparticle capable of combining a chemodynamic therapy and an immunotherapy is loaded with a traditional chemotherapeutic drug doxorubicin hydrochloride to serve as an inner core, and the outer layer is coated with a bionic lipid membrane with vitamin D3 and a neutrophile granulocyte membrane. According to the system, the inflammation chemotaxis and adhesion capacity of bionic neutrophil are utilized, specific delivery of glioma is achieved, manganese dioxide is further reduced into divalent manganese ions by responding to glutathione (GSH) in the tumor microenvironment in the glioma microenvironment, doxorubicin hydrochloride and vitamin D3 are released, finally cGAS-STING immune response is synergistically activated, and the glioma is specifically delivered. The compound can promote tumor cell apoptosis and reverse glioma immunosuppression microenvironment, and is especially used for multi-mode combined treatment of brain glioma.
Owner:JIANGYIN PEOPLES HOSPITAL +1

Immunogenic composition containing composite adjuvant as well as preparation method and application of immunogenic composition

The invention discloses an immunogenic composition containing a composite adjuvant as well as a preparation method and application of the immunogenic composition. The immunogenic composition comprises a gE-gI fusion protein, an immunopotentiator, namely, saponin QS-21, and a neutral liposome, the gE-gI fusion protein comprises a VZV gE, a connecting peptide and a VZV gI. The immunogenic composition provided by the invention only contains one immunopotentiator, can be applied to VZV vaccines, and solves the problems of relatively weak gE immunogenicity and relatively large clinical side reaction of the vaccines prepared in the prior art. The immunogenicity of the vaccine is equivalent to that of the Xinanlii, but the vaccine contains fewer immunopotentiators and has lower clinical side effects; in addition, the vaccine can also induce a gI specific antibody and gI specific CMI reaction, which is beneficial to further improvement of the effectiveness of the vaccine. In short, the immunogenic composition has good clinical application potential.
Owner:YUNNAN CHANGHE BIOTECHNOLOGY CO LTD

Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols

A formulation for drug delivery, providing enhanced modulation of solubility, stability, absorption, metabolism, and / or pharmacokinetic profile of a lipophilic therapeutic agent by formulation with sterols and / or sterol esters, resulting in higher bioavailability of a therapeutic agent administered to a subject in need of such therapeutic agent. The formulation contains a therapeutic agent and a sterol or sterol ester, and can, optionally, further contain a solubilizer and / or an enhancing agent. Also described are pharmaceutical compositions containing the formulations and methods of making and methods of using the formulations and pharmaceutical compositions. Formulations of the disclosure can be constituted to minimize the synthesis of dihydrotestosterone when the therapeutic agent includes testosterone or testosterone esters.
Owner:MARIUS PHARMACEUTICALS LLC

Antitumor effect potentiator

An activator suitable for immune response in tumor immunotherapy using an immune checkpoint inhibitor. An agent suitable for potentiating an antitumor effect of an immune checkpoint inhibitor, may contain a probiotic and a prebiotic as active ingredients.
Owner:NAT CEREBRAL & CARDIOVASCULAR CENT +1

Application of actinomycin D in preparation of ctDNA detection sensitizer

The invention belongs to the technical field of biological medicine, and particularly relates to application of actinomycin D in preparation of a ctDNA detection sensitizer. The invention provides a ctDNA release method based on actinomycin D as an enhancer, which can significantly improve the release level of ctDNA in early small-volume tumors and tiny residual lesions, thereby improving the sensitivity and positive detection rate of liquid biopsy in MRD detection. Under an extremely low dosage, the ActD can generally promote a plurality of human tumor cells to release ctDNA under the condition of not causing obvious cell death, and has good biological safety and adaptability. The method is especially suitable for tiny, biological inert or anatomical position hidden focuses which are difficult to identify by iconography, namely blind area patient groups in disease monitoring, and has a wide clinical application prospect.
Owner:SUN YAT SEN UNIV

Method for enhancing permeability of transdermal drug delivery by using biological material

The invention relates to the technical field of biological medicine and drug delivery, and discloses a method for enhancing the permeability of transdermal drug delivery by using a biological material, and the method comprises the following steps: S1, preparing a multifunctional nano-carrier containing a high-molecular polymer core and a functional shell layer; s2, mixing the multifunctional nano-carrier with a matrix material; s3, carrying out surface modification on the nano-carrier, and adding a targeting ligand or a penetration enhancer; s4, applying an intelligent responsive material which is a temperature-sensitive material or a pH-sensitive material and is used for controlling drug release when the temperature or the pH changes; and S5, adding a reinforcing agent into the matrix material, wherein the reinforcing agent is selected from hyaluronic acid, chitosan or other natural polysaccharides. Through a multi-layer nano-carrier, targeted ligand modification, an intelligent response material and a biodegradable microneedle, transdermal absorption, targeting and controlled release of the drug are improved, and the problems of insufficient absorption and poor targeting of a traditional system are solved.
Owner:WENZHOU HOSPITAL OF TRADITIONAL CHINESE MEDICINE

Compositions comprising sulforaphane or a sulforaphane precursor and a milk thistle extract or powder

The invention relates to the combination of a sulforaphane precursor, an enzyme capable of converting the sulforaphane precursor to sulforaphane, an enzyme potentiator, and a milk thistle extract or powder. The invention also relates to the combination of a sulforaphane or a derivative thereof and a milk thistle extract or powder. The invention also relates to the combination of a broccoli extract or powder and a milk thistle extract or powder. The invention provides compositions and methods relating to these combinations.
Owner:NUTRAMAX LABORATORIES INC

Adjuvant and composition thereof

To provide the use of a CBR1 agonist as an adjuvant and an adjuvant composition.SOLUTION: A compound represented by formula (1): Wherein R represents a cyclopropyl group or a 2-chloroethyl group. The antibody induction-promoting agent contains a compound represented by general formula (I) as an active ingredient.SELECTED DRAWING: None
Owner:DENKA CO LTD